| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |